# US 2022/0033879 A1 · Targeted enrichment by endonuclease protection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033879 A1
- Document ID: US20220033879A1
- Status: Published application
- Kind: A1
- Application number: 17/297,859
- Filed: 2019-11-27
- Published: 2022-02-03
- Earliest claimed: 2018-11-28
- Assignees: Keygene N.V.
- Applicants: Keygene N.V.
- Inventors: Stefan John WHITE; René Cornelis Josephus HOGERS
- Web page: https://patentgrep.com/patent/US20220033879A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The current invention pertains to a method for the enrichment of a target nucleic acid fragment from a nucleic acid sample, comprising the steps of cleaving the nucleic acid sample with a first and a second RNA guided or DNA guided endonuclease complex, preferably a first and a second gRNA-CAS complex, thereby generating the target nucleic acid fragment and at least one non-target nucleic acid fragment. The generated fragments are subsequently contacted with an exonuclease, wherein the exonuclease digests only the non-target nucleic acid fragments. The invention further pertains to the use of the enriched target nucleic acid fragments for preparing an adapter ligated target nucleic acid fragment and for sequencing the target nucleic acid fragment.

## Claims

### Claim 1

A method for enrichment of a target nucleic acid fragment from a sample comprising a nucleic acid molecule, wherein the target nucleic acid fragment comprises a sequence of interest, and wherein the method comprises the steps of:
a) providing the sample comprising the nucleic acid molecule, wherein the nucleic acid molecule comprises the sequence of interest;
b) cleaving the nucleic acid molecule with at least a first and a second gRNA-CAS complex, thereby generating the target nucleic acid fragment comprising the sequence of interest that is protected against exonuclease cleavage, and at least one non-target nucleic acid fragment;
c) contacting the cleaved nucleic acid molecules obtained in step b) with an exonuclease and allowing the exonuclease to digest the at least one non-target nucleic acid fragment; and
d) optionally purifying the target nucleic acid fragment comprising the sequence of interest from the digest obtained in step c).

### Claim 2 (depends on 1)

The method according to claim 1, wherein the method does not comprise a further step of protecting the target nucleic acid fragment, or the ends of the target nucleic acid fragment, prior to exonuclease digestion in step c).

### Claim 3 (depends on 1)

The method according to claim 1, wherein at least one of
i) step b) is performed by incubating the first and second gRNA-CAS complex and the nucleic acid molecule together for about 1 min to about 18 hours, preferably about 60 minutes, at about 10-90° C., preferably about 37° C.; and
ii) step c) is performed by incubating the cleaved nucleic acid molecule with the exonuclease for about 1 minute to about 12 hours, preferably 30 min, at about 10-90° C., preferably about 37° C.

### Claim 4 (depends on 1)

The method according to claim 1, wherein at least one of the first and second gRNA-CAS complex comprises a Cas9 protein.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the at least one of the first and second gRNA-CAS complex comprises a sgRNA.

### Claim 6 (depends on 1)

The method according to claim 1, wherein at least one of the first and second gRNA-CAS complex comprises a crRNA and a tracrRNA as separate molecules.

### Claim 7 (depends on 1)

The method according to claim 1, wherein at least one of the first and second gRNA-CAS complex is capable of inducing a DSB.

### Claim 8 (depends on 1)

The method according to claim 1, wherein both the first and the second gRNA-CAS complex are capable of inducing a DSB.

### Claim 9 (depends on 1)

The method according to claim 1, wherein in step b) at least one of the first and second gRNA-CAS complex nicks one strand of the nucleic acid molecule, and wherein the nucleic acid molecule is contacted with at least a third gRNA-CAS complex that nicks the complement strand at substantially the complementary position of the position nicked by said first or second gRNA-CAS complex.

### Claim 10

A method for preparing an adapter ligated target nucleic acid fragment from a sample comprising a nucleic acid molecule, wherein the target nucleic acid fragment comprises a sequence of interest, wherein the method comprises the steps of:
a) providing the sample comprising the nucleic acid molecule, wherein the nucleic acid molecule comprises the sequence of interest;
b) cleaving the nucleic acid molecule with at least a first and a second gRNA-CAS complex, thereby generating the target nucleic acid fragment comprising the sequence of interest and at least one non-target nucleic acid fragment;
c) contacting the cleaved nucleic acid molecules obtained in step b) with an exonuclease and allowing the exonuclease to digest the at least one non-target nucleic acid fragment;
d) optionally purifying the target nucleic acid fragment comprising the sequence of interest from the digest obtained in step c; and
e) ligating adapters to the target nucleic acid fragment.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the adapters are sequence adapters.

### Claim 12

A method for sequencing a target nucleic acid fragment from a sample comprising a nucleic acid molecule, wherein the target nucleic acid fragment comprises a sequence of interest, wherein the method comprises the steps of:
a) providing the sample comprising the nucleic acid molecule, wherein the nucleic acid molecule comprises the sequence of interest;
b) cleaving the nucleic acid molecule with at least a first and a second gRNA-CAS complex, thereby generating the target nucleic acid fragment comprising the sequence of interest and at least one non-target nucleic acid fragment;
c) contacting the cleaved nucleic acid molecules obtained in step b) with an exonuclease and allowing the exonuclease to digest the at least one non-target nucleic acid fragment;
d) optionally purifying the target nucleic acid fragment comprising the sequence of interest from the digest obtained in step c;
e) optionally ligating adapters to the target nucleic acid fragment; and
f) sequencing the at least one target nucleic acid fragment.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the method is performed in parallel for multiple nucleic acid samples.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the nucleic acid molecule is genomic DNA.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the nucleic acid molecule is a nucleic acid molecule obtainable from a plant, animal, human or microorganism.

### Claim 16 (depends on 1)

A kit of parts for enrichment of a target nucleic acid fragment from a nucleic acid molecule comprising:
at least a first and second gRNA-CAS complex as defined in claim 1 and
an exonuclease.

### Claim 17 (depends on 1)

A method for enrichment of at least one target nucleic acid fragment from a nucleic acid molecule comprising using a first and second gRNA-CAS complex of claim 1, or a kit of parts comprising at least a first and second gRNA-CAS complex as defined in claim 1 and an exonuclease.
